These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1345217)
1. Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage. Zanchetti A Blood Press; 1992 Dec; 1(4):205-11. PubMed ID: 1345217 [No Abstract] [Full Text] [Related]
2. Short- and long-term perspectives of antihypertensive therapy. An introduction. Zanchetti A Am J Hypertens; 1993 Mar; 6(3 Pt 2):2S-5S. PubMed ID: 8466721 [TBL] [Abstract][Full Text] [Related]
3. Let's Not SPRINT to Judgment About New Blood Pressure Goals. Ortiz E; James PA Ann Intern Med; 2016 May; 164(10):692-3. PubMed ID: 26902415 [No Abstract] [Full Text] [Related]
4. Time to lower treatment BP targets for hypertension? Carlberg B Lancet; 2009 Aug; 374(9689):503-4. PubMed ID: 19683626 [No Abstract] [Full Text] [Related]
5. [Hypertension and cardiovascular damage]. Zanchetti A Ann Ital Med Int; 1992; 7(3 Suppl):97S-99S. PubMed ID: 1297404 [TBL] [Abstract][Full Text] [Related]
7. Is diltiazem as effective as diuretics and beta-blockers in preventing complications from hypertension? Adelman A J Fam Pract; 2000 Nov; 49(11):1049. PubMed ID: 11093573 [No Abstract] [Full Text] [Related]
8. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?]. Coca A; Ruilope LM Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874 [No Abstract] [Full Text] [Related]
9. Cardiovascular consequences of hypertension: therapeutic effects on organ damage and on cardiovascular events. Zanchetti A Blood Press Suppl; 1994; 1():1-4. PubMed ID: 8205291 [TBL] [Abstract][Full Text] [Related]
10. Goals of antihypertensive treatment and planning of therapeutic trials. Zanchetti A Am J Hypertens; 1994 Jul; 7(7 Pt 2):13S-15S. PubMed ID: 7946172 [TBL] [Abstract][Full Text] [Related]
11. Preventing vascular events due to elevated blood pressure. Yusuf S Circulation; 2006 May; 113(18):2166-8. PubMed ID: 16684871 [No Abstract] [Full Text] [Related]
12. Legacy Effect in the Treatment of Hypertension: Persistent Cardiovascular Protection after Conclusion of Randomized Clinical Trials in Hypertension. Gallo G; Battistoni A; Coluccia R; Tocci G; Volpe M Curr Hypertens Rep; 2019 Oct; 21(11):85. PubMed ID: 31599359 [TBL] [Abstract][Full Text] [Related]
13. Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE. Kjeldsen SE; Westheim AS; Os I Curr Hypertens Rep; 2005 Jun; 7(3):155-7. PubMed ID: 15913486 [No Abstract] [Full Text] [Related]
14. [The pharmacotherapy of arterial hypertension and the prevention of cardiovascular events. From evidence-based medicine to the new therapeutic opportunities]. Taddei S Recenti Prog Med; 1999 Jan; 90(1):4-8. PubMed ID: 10193156 [No Abstract] [Full Text] [Related]
17. Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus. Nilsson PM; Cifkova R; Kjeldsen SE J Hypertens; 2006 Jan; 24(1):208-10. PubMed ID: 16331123 [No Abstract] [Full Text] [Related]
18. Diuretics for cardiovascular prevention in the elderly. Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568 [TBL] [Abstract][Full Text] [Related]
19. Hypertension strategies for therapeutic intervention and prevention of end-organ damage. Houston MC Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795 [TBL] [Abstract][Full Text] [Related]
20. Initial antihypertensive therapy. What are the current drugs of choice? Yeun JY Postgrad Med; 2001 Nov; 110(5):39-40, 43-4, 47-8 passim. PubMed ID: 11727652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]